![System.Func`1[System.String]](/siteassets/images/z-mckesson-logosicons/health-systems2.png)
The first in a series of interviews with our Specialty Pharmacy Enablement expert, Ginger Thorpe, covering important questions health systems should be asking.
Considerations for Integrating Cell & Gene Therapies into Community Hospitals
Insights on expanding access to CGT treatments within community healthcare systems.
By
Date
June 05, 2024
Read time: 4 minutes
By: Joe DePinto
The second of a two-part article recently published by Cell & Gene and coauthored by Joe DePinto, Head of Cell, Gene, & Advanced Therapies at McKesson, emphasizes the need to deliver the right treatments at the right time and place. The article explores strategies for integrating cell and gene therapies (CGTs) into community hospitals, considering factors like geographic location, patient access, and clinical outcomes. Operational challenges and financial implications of bringing CGTs to community settings – including infrastructure, training, and reimbursement issues – are also discussed. Read the full article, Part 2: Getting The System Ready: Enabling Investment In Community Hospitals To Improve Patient Access To Cell And Gene Therapies, on Cell & Gene.
Subscribe Now
To learn how McKesson can help health systems achieve more, sign up to have the Prescribed Perspectives newsletter delivered directly to your inbox.
Related Stories
The top three Prescribed Perspectives articles downloaded by health systems in June.
This visual helps illustrate the nuances of each type of bagging in specialty pharmacy and what it may mean for your health system.
As strategic partners, our Specialty Pharmacy Enablement experts can help drive improvements across the board.
In a unique, retreat-style setting, health systems leaders had close conversations around best practices, wins, struggles, and solutions.
Discover three key takeaways from a recent C-suite roundtable discussing the benefits and challenges of central fill for health systems.
Industry event highlights how connection, creativity, and a fresh perspective are shaping the future of health system innovation.
Our comprehensive and customizable solutions are deliberately designed with real customer challenges in mind.
McKesson’s Prateek Bhatia, VP/GM, Intrafusion, shares insights on the many opportunities health systems have with their infusion service line.
Expert insights on the rapid growth of specialty pharmacy and the importance of strategic integration.